Please ensure Javascript is enabled for purposes of website accessibility

Israel's Prime Minister Says Country Could Follow Canadian Model of Pot Legalization

By Eric Volkman - Feb 24, 2020 at 7:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Benjamin Netanyahu also aims to expunge the criminal records of those persecuted for marijuana offenses.

The Israeli government could go the route of full marijuana legalization with criminal amnesty, if a recent tweet from its leader is anything to go by.

On Sunday, Prime Minister Benjamin Netanyahu wrote that he aims to purge the criminal records of Israelis convicted of cannabis-related offenses. According to him, the number of affected people reaches into the "tens of thousands".

Netanyahu added that Justice Minister Amir Ohana has started work on this issue. Ohana is also to lead a committee that will look into using the Canadian model to legalize cannabis in the country. That committee will include legal and medical professionals, Netanyahu wrote.

Old City Jerusalem in Israel.

Image source: Getty Images.

At the moment, Israel allows the sale and consumption of medical marijuana, albeit with fairly strict limits. Recreational cannabis remains illegal, although the country recently decriminalized it -- first-time offenders caught with up to 15 grams of the drug may be fined 1,000 shekels ($291).

Canada allows both medical and recreational use, having famously legalized the latter starting in October 2018.

Israel's medical cannabis sector is small but thriving, and for much of its existence it has been a purely domestic industry. Recently, however, Canadian marijuana company Tilray (TLRY) announced that it signed a supply deal with Israeli marijuana importer-exporter Canndoc for medical cannabis. Tilray will ship as much as 2.5 metric tons of product to the country from a facility it operates in Portugal.

One reason for the Tilray deal is that the Israeli cannabis industry has experienced domestic supply shortages. If the country liberalizes its marijuana laws to any degree, these could become significantly more acute, increasing the need for assistance from foreign companies like Tilray.

On Monday, a very poor day for stocks overall, Tilray's share price fell by almost 11%.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/13/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.